[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-detail-345287-en":59,"doc-seo-345287-105":98},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":5,"data":60},{"doc_id":61,"user_id":62,"nickname":63,"user_avatar":64,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":66,"doc_content":67,"file_id":68,"file_url":69,"file_type":70,"file_size":71,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":72,"language_code":73,"site_id":74,"html_lang":73,"table_of_contents":75,"faqs":76,"seo_title":77,"seo_description":66,"update_tm":78,"read_time":79,"preview_page_count":19,"preview_urls":80},345287,8796095461564,"Liam","https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","IRS4 is a PI3K-activating cancer dependency up-regulated through DNA rearrangements or epigenetic mechanisms in multiple solid tumors","Cancer therapeutics often fail in clinical trials due to a poor therapeutic index, so target selection and mechanistic rationale are crucial. This study systematically identifies genes likely to yield favorable therapeutic indices and highlights insulin receptor substrate 4 (IRS4) as a cancer dependency in IRS4-expressing tumors. Pan-cancer analysis reports dependency-associated IRS4 expression across pediatric-enriched cancers and lower levels in adult malignancies. IRS4 upregulation arises from enhancer hijacking rearrangements in adult tumors and epigenetic mechanisms in pediatric-associated cancers, driving PI3K-Akt signaling, with domain analyses suggesting degradation-based inhibitory strategies.","CANCER  \nIRS4 is a PI3K-activating cancer dependency up-regulated through DNA rearrangements or epigenetic mechanisms in multiple solid tumors  \nKhadija Banu1†, Mohammad Aslam Khan1†, Sihan Li1, Morgan Reynolds-Gagliano2, Xiaofei Wang3, Robert J. Mobley1, Kelly R. Barnett1, Matthew M. Wielgosz4, Matthew Bauler4, Christopher Wincek4, Kiran Kodali5, Wei Wang5, Vishwajeeth Pagala5, Anthony A. High5, Daniel Putnam6, Rishi S. Kotecha7,8, Laurence C. Cheung7,8, Xiaotu Ma6, Robert E. Throm4, Shondra M. Pruett-Miller2, Daniel Savic1, Samuel W. Brady1,6*  \nCancer therapeutics frequently fail in clinical trials because of poor therapeutic index (efficacy-to-toxicity ratio). We systematically identified targets likely to have a good therapeutic index, revealing insulin receptor substrate 4 (IRS4) asa dependency in IRS4-expressing cancers. Pan-cancer analysis of pediatric-enriched cancers revealed IRS4 expression consistent with dependency in 68% of choroid plexus, 37% of malignant rhabdoid, 31% of NUT midline, and 5% of osteosarcomas, while in adult cancers, it was expressed in 8% of uterine leiomyosarcomas and 1 to 2% of lungsquamous, stomach, and breast carcinomas. IRS4 expression in adult tumors was associated with enhancer hijacking rearrangements, including recurrent GATA3-IRS4 and ANKRD30A-IRS4 in breast cancer, while rhabdoid and NUT midline cancers expressed IRS4 epigenetically. IRS4 fueled cancer dependency through PI3K-Akt activation, and domain analysis revealed thePHand PTBdomains, which have a predicted drug pocket, to be dispensable, suggesting degradation-based modalities. These data reveal IRS4 as a target in IRS4-expressing cancers and suggest inhibitory approaches.  \ncopyright © 2026 the Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. no claim to original U.S.  \nGovernment Works. distributed under a creative commons Attribution noncommercial license 4.0 (cc BY-nc) .  \nINTRODUCTION  \nOnly 3 to 15% of anticancer therapeutics entering phase 1 clinical trials ultimately become US Food and Drug Administration (FDA) approved (1–4), which is the lowest rate among major diseases (2). This challenge is partly because cancer relies on therapeutic targets that are also found in normal cells, given that cancer arises from normal tissues. The ability of a therapy to reduce tumor burden while minimizing toxicity is conceptualized as the therapeutic index, with a high index indicating strong antitumor efficacy and low normal-tissue toxicity (5). The ability to a priori predict targets with a good therapeutic index would increase the likelihood of FDA approval through improved target selection.  \nThe Dependency Map (DepMap) (6) effort has assessed the fitness effects of knocking out each coding gene in >1000 cancer cell lines, thus facilitating the identification of cancer targets. Selectively dependent genes (necessary in a subset of cancer cell lines but dispensable for most) have been suggested to have a less toxic, targeted therapy–like profile when drugged, while “pan-essential” genes (necessary in all cell lines) are likely to result in chemotherapy-like toxicity when drugged (5) . Moreover, large human genetic datasets such as gnomAD (7), the UK Biobank (8), and germline genetic studies have enabled the systematic  \n1department of Pharmacy and Pharmaceutical Sciences, St. Jude children’s Research hospital, Memphis, tn, USA. 2department ofcell and Molecular Biology and center for Advanced Genome engineering, St. Jude children’s Research hospital, Memphis, tn, USA. 3Animal Resources center, St. Jude children’s Research hospital, Memphis, tn, USA.4vector development and Production laboratory, St. Jude children’s Research hospital, Memphis, tn, USA. 5center for Proteomics and Metabolomics, St. Jude children’s Research hospital, Memphis, tn, USA. 6department of computational Biology, St. Jude children’s Research hospital, Memphis, tn, USA. 7leukaemia translational Research labora","cbCainZsur4CJpCr","https://ap.wps.com/l/cbCainZsur4CJpCr","pdf",5152083,"English","en",105,"# Introduction\n## Therapeutic index and target selection\n## Dependency Map and genetic datasets\n## Study aim and IRS4 mechanisms","[{\"question\":\"Why do many anticancer drugs fail in clinical trials?\",\"answer\":\"They often fail because of a poor therapeutic index, meaning inadequate efficacy relative to toxicity. The core difficulty is that many therapeutic targets also exist in normal cells.\"},{\"question\":\"How does the study identify cancer dependencies with a favorable therapeutic index?\",\"answer\":\"It uses Dependency Map (DepMap) fitness effects from gene knockouts across large cancer cell line collections, combined with human germline evidence of nonessentiality. This points to targets that may be less toxic when inhibited.\"},{\"question\":\"What mechanisms increase IRS4 expression in different cancer groups?\",\"answer\":\"In adult tumors, IRS4 expression is linked to enhancer hijacking rearrangements, including recurrent fusion-like enhancer contexts. In pediatric-enriched cancers, IRS4 expression is driven primarily by epigenetic mechanisms.\"}]","IRS4 is a PI3K-activating cancer dependency up-regulated through DNA rearrangements or epigenetic mechanisms in multiple solid tumors | PDF",1790057133,48,[81,85,89,94],{"page_no":8,"url":82,"width":83,"height":84},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89cbdb3c5838e75935214299f88ad4f6.webp",983,1250,{"page_no":14,"url":86,"width":87,"height":88},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8ba51978e22aee1c92c96e57c5d0d980.webp",982,1249,{"page_no":90,"url":91,"width":92,"height":93},3,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c867441265d253d4166e4f511e6bc95.webp",981,1248,{"page_no":19,"url":95,"width":96,"height":97},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/53f3a2ab2850f8cd00c9725908f2ab4d.webp",980,1247,{"code":4,"msg":99,"data":100},"ok",{"site_id":74,"language":73,"slug":101,"title":65,"keywords":102,"description":66,"schema_data":103,"social_meta":156,"head_meta":158,"extra_data":160,"updated_unix":161},"irs4-is-a-pi3k-activating-cancer-dependency-up-regulated-through-dna-rearrangements-or-epigenetic-mechanisms-in-multiple-solid-tumors","",{"@graph":104,"@context":155},[105,118,138],{"@type":106,"itemListElement":107},"BreadcrumbList",[108,112,114,116],{"item":109,"name":110,"@type":111,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":113,"name":9,"@type":111,"position":14},"https://docshare.wps.com/document/",{"item":115,"name":40,"@type":111,"position":90},"https://docshare.wps.com/document/research-report/",{"item":117,"name":65,"@type":111,"position":19},"https://docshare.wps.com/document/irs4-is-a-pi3k-activating-cancer-dependency-up-regulated-through-dna-rearrangements-or-epigenetic-mechanisms-in-multiple-solid-tumors/345287/",{"url":117,"name":65,"@type":119,"image":120,"author":125,"headline":65,"publisher":127,"fileFormat":130,"inLanguage":73,"description":66,"dateModified":131,"datePublished":132,"encodingFormat":130,"isAccessibleForFree":133,"interactionStatistic":134},"DigitalDocument",{"url":121,"@type":122,"width":123,"height":124},"https://docshare.wps.com/thumbnails/irs4-is-a-pi3k-activating-cancer-dependency-up-regulated-through-dna-rearrangements-or-epigenetic-mechanisms-in-multiple-solid-tumors/345287.png","ImageObject",300,407,{"name":63,"@type":126},"Person",{"url":109,"name":128,"@type":129},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":135,"interactionType":136,"userInteractionCount":24},"InteractionCounter",{"@type":137},"ViewAction",{"@type":139,"mainEntity":140},"FAQPage",[141,147,151],{"name":142,"@type":143,"acceptedAnswer":144},"Why do many anticancer drugs fail in clinical trials?","Question",{"text":145,"@type":146},"They often fail because of a poor therapeutic index, meaning inadequate efficacy relative to toxicity. The core difficulty is that many therapeutic targets also exist in normal cells.","Answer",{"name":148,"@type":143,"acceptedAnswer":149},"How does the study identify cancer dependencies with a favorable therapeutic index?",{"text":150,"@type":146},"It uses Dependency Map (DepMap) fitness effects from gene knockouts across large cancer cell line collections, combined with human germline evidence of nonessentiality. This points to targets that may be less toxic when inhibited.",{"name":152,"@type":143,"acceptedAnswer":153},"What mechanisms increase IRS4 expression in different cancer groups?",{"text":154,"@type":146},"In adult tumors, IRS4 expression is linked to enhancer hijacking rearrangements, including recurrent fusion-like enhancer contexts. In pediatric-enriched cancers, IRS4 expression is driven primarily by epigenetic mechanisms.","https://schema.org",{"og:url":117,"og:type":157,"og:title":65,"og:site_name":128,"og:description":66},"article",{"robots":159,"canonical":117},"index,follow",{"doc_id":61,"site_id":74},1790196929]